Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Stud Russ Econ Dev ; 34(1): 77-85, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37033716

RESUMO

The article is devoted to the analysis of the dynamics of labor markets in the regions of the European part of the Russian Arctic based on the indicators of the balance of labor resources after 2013. It is shown that the trends in these regions are much more unfavorable compared to the country as a whole. A significant reduction in the size of labor markets is expected, which will slow down the socio-economic development of these territories.

2.
Artigo em Russo | MEDLINE | ID: mdl-30499494

RESUMO

AIM: To evaluate the efficacy of cytoflavin inclusion in the complex therapy of patients with multiple sclerosis in the remitting form during the period of exacerbation. MATERIAL AND METHODS: The results of therapy of 41 patients matched for sex, age and parameters of clinical and laboratory data were analyzed. Depending on the scheme of therapy, patients were divided into 2 groups: patients of the first group (n=22) received hormonal therapy with methylprednisolone. Patients of group II (n=19) received cytoflavin. The efficacy of treatment was assessed by a set of clinical and laboratory indicators in dynamics - before the start of therapy, with a 10-day interval and after treatment. The neurological status was assessed with the most commonly used scales (functional system scale (FS), EDSS scale), also neuroimaging data were assessed. RESULTS AND CONCLUSION: The inclusion of cytoflavin as an antioxidant and neuroprotective agent in the therapy of patients with multiple sclerosis in the acute phase increased the efficacy of basic (hormonal) therapy, which is manifested in a significant decrease in the severity of neurologic symptoms and visual system disorders and fewer cases of non-response to treatment.


Assuntos
Mononucleotídeo de Flavina , Inosina Difosfato , Esclerose Múltipla , Niacinamida , Succinatos , Combinação de Medicamentos , Mononucleotídeo de Flavina/uso terapêutico , Humanos , Inosina Difosfato/uso terapêutico , Esclerose Múltipla/tratamento farmacológico , Niacinamida/uso terapêutico , Succinatos/uso terapêutico , Resultado do Tratamento
4.
Mol Gen Mikrobiol Virusol ; (6): 12-6, 1994.
Artigo em Russo | MEDLINE | ID: mdl-7537856

RESUMO

High-level expression vector pAZ was constructed for in vivo delivery of bioactive recombinant proteins, antigenic determinants, among other things. This vector meets the requirements to construction of recombinant bacteria as live oral carriers. It has a strong constitutive promoter, high stability in E.coli and vaccine strain Salmonella cells, and, moreover, encodes in addition for the marker protein (beta-galactosidase) which will later help follow up the fate of bacterial carriers and their interactions in the microorganism. Several recombinant plasmids encoding for beta-galactosidase variants with insertions of short fragments of HIV-1 gp41 and gp120 proteins, which were previously shown to be antigenic determinants, have been constructed on the basis of pAZ. E.coli and vaccine strain Salmonella cells were transformed by recombinant plasmids. To a considerable extent the level of hybrid protein synthesis depends on the structure of the antigenic determinant inserted. The maximal level of synthesis in E.coli is 16%. This hybrid protein could be isolated and purified (up to 90%) with the yield of 4 to 6 mg/g of wet cells. Almost all the hybrid proteins were immunologically reactive, as shown by ELISA with nonfractionated lysates and purified hybrids. In both strains in vitro stability of the vector and recombinant plasmids was at least 90% after 10 passages (about 140 generations) under random conditions. This paper sums up the first stage of construction of recombinant bacteria as live oral carriers.


Assuntos
Epitopos/genética , Escherichia coli/genética , Proteína gp120 do Envelope de HIV/imunologia , Proteína gp41 do Envelope de HIV/imunologia , Plasmídeos , Salmonella/genética , Sequência de Aminoácidos , Sequência de Bases , Ensaio de Imunoadsorção Enzimática , Dados de Sequência Molecular , Proteínas Recombinantes/genética , beta-Galactosidase/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...